Your browser doesn't support javascript.
loading
Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis.
Keil, Radan; Wasserbauer, Martin; Zádorová, Zdena; Hajer, Jan; Drastich, Pavel; Wohl, Pavel; Benes, Marek; Bojková, Martina; Svoboda, Pavel; Konecný, Michal; Falt, Premysl; Vanásek, Tomás; Pesta, Martin; Pesek, Frantisek; Bouchner, Ludek; Kozeluhová, Jana; Novotný, Ales; Bartusková, Lucie; Spicák, Julius.
Afiliação
  • Keil R; a Department of Internal Medicine, 2nd Faculty of Medicine , Charles University in Prague and Motol University Hospital , Prague , Czech Republic ;
  • Wasserbauer M; a Department of Internal Medicine, 2nd Faculty of Medicine , Charles University in Prague and Motol University Hospital , Prague , Czech Republic ;
  • Zádorová Z; b 2nd Department of Internal Medicine, 3rd Faculty of Medicine , Charles University in Prague, FNKV , Prague , Czech Republic ;
  • Hajer J; b 2nd Department of Internal Medicine, 3rd Faculty of Medicine , Charles University in Prague, FNKV , Prague , Czech Republic ;
  • Drastich P; c Department of Hepatogastroenterology , Institute for Clinical and Experimental Medicine , Prague , Czech Republic ;
  • Wohl P; c Department of Hepatogastroenterology , Institute for Clinical and Experimental Medicine , Prague , Czech Republic ;
  • Benes M; c Department of Hepatogastroenterology , Institute for Clinical and Experimental Medicine , Prague , Czech Republic ;
  • Bojková M; d Clinic of Internal Medicine, University Hospital Ostrava , Ostrava , Czech Republic ;
  • Svoboda P; d Clinic of Internal Medicine, University Hospital Ostrava , Ostrava , Czech Republic ;
  • Konecný M; e 2nd Department of Internal Medicine , University Hospital Olomouc , Olomouc , Czech Republic ;
  • Falt P; f Digestive Diseases Center, Vítkovice Hospital , Ostrava , Czech Republic ;
  • Vanásek T; g 2nd Department of Internal Medicine-Gastroenterology , University Hospital Hradec Králové, Hradec Králové , Czech Republic ;
  • Pesta M; h Department of Internal Medicine , Hospital Na Bulovce , Prague , Czech Republic ;
  • Pesek F; i 2nd Department of Internal Medicine , University Hospital Plzen-Bory , Plzen, Czech Republic ;
  • Bouchner L; i 2nd Department of Internal Medicine , University Hospital Plzen-Bory , Plzen, Czech Republic ;
  • Kozeluhová J; j 4th Department of Internal Medicine - Clinic of Gastroenterology and Hepatology , The General University Hospital in Prague, 1st Medical Faculty, Charles University in Prague , Prague , Czech Republic ;
  • Novotný A; j 4th Department of Internal Medicine - Clinic of Gastroenterology and Hepatology , The General University Hospital in Prague, 1st Medical Faculty, Charles University in Prague , Prague , Czech Republic ;
  • Bartusková L; k Department of Economic and Social Policy , University of Economics , Prague , Czech Republic.
  • Spicák J; c Department of Hepatogastroenterology , Institute for Clinical and Experimental Medicine , Prague , Czech Republic ;
Scand J Gastroenterol ; 51(9): 1062-8, 2016 Sep.
Article em En | MEDLINE | ID: mdl-27002981

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Colite Ulcerativa / Doença de Crohn / Medicamentos Biossimilares / Infliximab / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Scand J Gastroenterol Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Colite Ulcerativa / Doença de Crohn / Medicamentos Biossimilares / Infliximab / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Scand J Gastroenterol Ano de publicação: 2016 Tipo de documento: Article